FR2211215A1 - Colour-stabilising cephalosporin parenteral solns. - with sulphur cpds., monothioglycerol or thiourea - Google Patents

Colour-stabilising cephalosporin parenteral solns. - with sulphur cpds., monothioglycerol or thiourea

Info

Publication number
FR2211215A1
FR2211215A1 FR7346293A FR7346293A FR2211215A1 FR 2211215 A1 FR2211215 A1 FR 2211215A1 FR 7346293 A FR7346293 A FR 7346293A FR 7346293 A FR7346293 A FR 7346293A FR 2211215 A1 FR2211215 A1 FR 2211215A1
Authority
FR
France
Prior art keywords
solns
monothioglycerol
thiourea
parenteral
colour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7346293A
Other languages
English (en)
French (fr)
Other versions
FR2211215B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2211215A1 publication Critical patent/FR2211215A1/fr
Application granted granted Critical
Publication of FR2211215B1 publication Critical patent/FR2211215B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
FR7346293A 1972-12-26 1973-12-26 Colour-stabilising cephalosporin parenteral solns. - with sulphur cpds., monothioglycerol or thiourea Granted FR2211215A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31805472A 1972-12-26 1972-12-26

Publications (2)

Publication Number Publication Date
FR2211215A1 true FR2211215A1 (en) 1974-07-19
FR2211215B1 FR2211215B1 (enrdf_load_stackoverflow) 1977-09-09

Family

ID=23236430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7346293A Granted FR2211215A1 (en) 1972-12-26 1973-12-26 Colour-stabilising cephalosporin parenteral solns. - with sulphur cpds., monothioglycerol or thiourea

Country Status (5)

Country Link
JP (1) JPS4994820A (enrdf_load_stackoverflow)
BE (1) BE809060A (enrdf_load_stackoverflow)
DE (1) DE2364470A1 (enrdf_load_stackoverflow)
FR (1) FR2211215A1 (enrdf_load_stackoverflow)
NL (1) NL7317644A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600534A1 (fr) * 1986-06-26 1987-12-31 Senju Pharma Co Procede pour empecher la coloration de preparations aqueuses de cefmenoxime.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115645A (en) * 1977-05-10 1978-09-19 Eli Lilly And Company Decolorizing process for 7-amino-3-(((2-methyl-1,3,4-thiadiazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1272453A (fr) * 1954-08-02 1961-09-29 Merck & Co Inc Procédé de stabilisation de solutions aqueuses de streptomycine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1272453A (fr) * 1954-08-02 1961-09-29 Merck & Co Inc Procédé de stabilisation de solutions aqueuses de streptomycine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600534A1 (fr) * 1986-06-26 1987-12-31 Senju Pharma Co Procede pour empecher la coloration de preparations aqueuses de cefmenoxime.

Also Published As

Publication number Publication date
NL7317644A (enrdf_load_stackoverflow) 1974-06-28
FR2211215B1 (enrdf_load_stackoverflow) 1977-09-09
JPS4994820A (enrdf_load_stackoverflow) 1974-09-09
BE809060A (fr) 1974-06-21
DE2364470A1 (de) 1974-06-27

Similar Documents

Publication Publication Date Title
FR2211215A1 (en) Colour-stabilising cephalosporin parenteral solns. - with sulphur cpds., monothioglycerol or thiourea
GB1396756A (en) Method of regenerating chelating resins
GB1422942A (en) Penicillin g 1-s-oxide acetone solvate
GB826436A (en) Non-sulfur cure of rubbery copolymers
GB901675A (en) Process for improving the storage qualities of conserved whole-blood
FR2037001A1 (fr) Nouveaux dérivés du mercaptobenzothiazole
GB1038238A (en) Improvements in or relating to sodium cyclohexylsulfamate production
IL37211A (en) The manufacture of carbon disulphide with recovery of sulphur
FR2186471A1 (en) Tetramethylspiro-(4,5)-decane-dithione derivs - inter polymer stabiliser
GB1007873A (en) Process for the manufacture of boric acid from calcium borate ores
ES389471A1 (es) Procedimiento para la preparacion de tiofosgeno.
FR2042789A5 (en) Bis (pyridoxine 3-3 methyl) disulphides useful - as neuroleptics
ES232762A1 (es) UN PROCEDIMIENTO PARA LA ESTABILIZACIoN DE E-CAPROLACTAMA
BE779887A (fr) Vulcanisation de caoutchoucs a l'aide d'une combinaison acceleratrice contenant notamment un disulfure de 1,3,5-triazine
GB902992A (en) Antibiotic derivatives
GB915784A (en) Process for the purification of carbon tetrachloride
GB999791A (en) New penicillin
GB950900A (en) Process for the preparation of thiophene-2,5-dicarboxylic acid
ES272260A1 (es) Procedimiento para la obtencion de productos tenidos de celulosa regenerada
GB844117A (en) Recovery of contaminated guanidine thiocyanate
GB1286543A (en) S,s-substituted 2,2-thio-, sulfinyl-, and sulfonyl-alkanyl and -alkanone oximes
BE592816A (fr) Solution aqueuse de trypsine essentiellement stabilisée.
FR2187825A1 (en) Polystyrene compsns - contg bis-phenoxy cpds as flame-retardants
GB927423A (en) Dipiperazine sulphate solutions and method therefor
AU461557B2 (en) Process forthe manufacture of carbon disulphide with recovery of sulphur

Legal Events

Date Code Title Description
ST Notification of lapse